BARDA enlisting start-ups in fight against COVID-19 via JLABS collaboration

JLABS funneling start-up innovation to BARDA via Blue Knight initiative

August 28, 2020 11:25 PM UTC

A collaboration between JLABS and BARDA gives the government agency access to start-ups that it needs to fast track new, innovative COVID-19 therapies and diagnostics it otherwise would struggle to find.

The Johnson & Johnson (NYSE:JNJ) incubator and the Biomedical Advanced Research and Development Authority (BARDA) launched the Blue Knight collaboration in April of 2019 to accelerate development of technologies that can address public health threats, including emerging infectious diseases...